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Human cancers with a high frequency microsatellite instability phenotype develop due to defects in DNA mismatch repair
genes. Silencing of a DNA mismatch repair gene, hMLH1 gene, by promoter hypermethylation is a frequent cause of the
microsatellite instability-H phenotype. Using methylation speciﬁc PCR we investigated the methylation status of the hMLH1
gene promoter in 17 solitary gastric cancers (12 microsatellite instability-H and ﬁve microsatellite stable tumours from 17
patients), and 13 multiple gastric cancers (eight microsatellite instability-H, one low frequency microsatellite instability-L and
four microsatellite stable tumours from ﬁve patients) and also examined non-cancerous gastric mucosa both adjacent to and
distant from each tumour. Expression of hMLH1 protein was evaluated by immunohistochemistry. All microsatellite instability-
H tumours (20 out of 20) had evidence of methylation of hMLH1 promoter, whereas only one out of 10 microsatellite
instability-L and microsatellite stable tumours did (P50.0000005), and the methylation status correlated with hMLH1 protein
expression (P50.000003). Furthermore, methylation of the hMLH1 promoter was detected in 50% (6 out of 12) and 63% (5
out of 8) of non-cancerous gastric mucosa samples adjacent to, and in 33% (4 out of 12) and 40% (2 out of 5) of those
obtained from distant portion of, solitary and multiple cancers with microsatellite instability-H. Thus both solitary and multiple
gastric cancers with microsatellite instability-H have evidence of similar high levels of hMLH1 promoter hypermethylation in the
surrounding non-cancerous tissue. Hypermethylation of the hMLH1 promoter occurs in non-cancerous gastric mucosa of
microsatellite instability-H tumours and may increase the risk of subsequent neoplasia.
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Microsatellite instability (MSI) due to defects in mismatch repair
genes such as hMLH1 and hMSH2 is now widely recognized as an
important mechanism in tumorigenesis (Aaltonen et al, 1993; Ionov
etal, 1993; Thibodeau et al, 1996; Fleisher et al, 1999; Kang et al, 1999;
Leung et al, 1999; Suzuki et al, 1999; Toyota et al, 1999a). MSI is
reportedly present in 15–33% of solitary gastric cancers, although
mutations of the hMLH1 or hMSH2 genes are rare in sporadic gastric
cancers (Chong et al, 1994; Mironov et al, 1994; Strickler et al, 1994;
Tamura et al, 1996). Hypermethylation of promoter region CpG
islands is a common mechanism by which tumour suppressor or
tumour-related genes, and DNA mismatch repair genes are inacti-
vated (Herman et al, 1995, 1998; Kane et al, 1997; Baylin et al,
1998; Jones and Laird, 1999). Aberrant DNA methylation of promo-
ter region CpG islands of several genes, including retinoblastoma
(Rb), von Hippel-Lindau (VHL), p16, p15, APC, E-cadherin and
hMLH1 has been reported in human cancers, and silencing of hMLH1
by promoter hypermethylation is the major causative event in the
development of human cancers with MSI phenotype, including
gastric cancers (Graff et al, 1997; Kane et al, 1997; Herman et al,
1998; Fleisher et al, 1999; Kang et al, 1999; Leung et al, 1999; Suzuki
et al, 1999; Tamura et al, 2000; Tsuchiya et al, 2000).
To clarify the role of hypermethylation of the hMLH1 gene
promoter in the development of multiple gastric cancers, we
compared both the methylation status and expression of the
hMLH1 gene, in solitary and multiple gastric cancers with and
without MSI. In addition, we examined the methylation status of
the hMLH1 gene in non-cancerous gastric mucosa adjacent to
and distant from each tumour.
MATERIALS AND METHODS
Samples and DNA extraction
Thirty gastric adenocarcinomas, including 17 solitary tumours from
17 patients and 13 multiple tumours from ﬁve patients were studied.
The patients ranged in age from 59 to 84 years (average 72 years). We
also examined non-cancerous gastric tissue both adjacent to (at a
distance of 2 mm) and distant from (at a distance of 5 cm or surgical
margin) each tumour. The tumours were histologically differentiated
adenocarcinomas comprising 28 early cancers (depth of invasion
limited to the mucosa or submucosa) and two advanced cancers.
Specimens were ﬁxed in 10% buffered formalin. The carcinomas were
cut serially into 5 mm slices in parallel with the lesser curvature and
then embedded in parafﬁn. From one block that included the maxi-
mum diameter of the tumour, we prepared two sets of 3 and 10 mm
thick serial sections. The 3 mm thick sections were used for haema-
toxylin-eosin and immunohistochemical stainings, and each set of
the 10 mm thick sections for DNA extraction of cancerous or non-
cancerous DNA. To avoid contamination, either of cancerous or
non-cancerous the area was carefully dissected using disposable scal-
pels by a reference to the serial haematoxylin-eosin stained sections
under the microscope. DNA extraction was as described by Goelz
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12 microsatellite markers, i.e. D2S115, D4S404, D5S178, IL9,
D6S265, D7S490, D11S900, MYH6, TP53, D17S1176, D18S46, and
D21S1407, and deﬁned as MSI-H if there were more than 30%
unstable loci, MSI-L less than 30% unstable loci, and microsatellite
stable (MSS) no unstable loci (Ohmura et al, 2000; Ogata et al,
2001). Our samples constituted of 20 (12 solitary and eight multiple)
MSI-H tumours, 1 MSI-L tumour and nine (ﬁve solitary and four
multiple) MSS tumours.
Methylation-speciﬁc PCR
hMLH1 gene promoter methylation patterns were determined by
methylation speciﬁc PCR (MSP), as described previously (Fleisher
et al, 1999). MSP distinguishes unmethylated from methylated
alleles of a given gene based on sequence changes that are produced
following bisulﬁte treatment of DNA, which converts unmethylated
cytosines to uracils, while leaving methylated cytosines unaffected.
Subsequent PCR using primers speciﬁc to sequences that corre-
spond to either methylated or unmethylated hMLH1 gene
promoter DNA was performed. The primer sequences of hMLH1
for the unmethylated reaction were 5'-TTT TGA TGT AGA TGT
TTT ATT AGG GTT GT-3' (sense) and 5'-ACC ACC TCA TCA
TAA CTA CCC ACA-3' (antisense), whereas for the methylated
reaction they were 5'-ACG TAG ACG TTT TAT TAG GGT
CGC-3' (sense) and 5'-CCT CAT CGT AAC TAC CCG CG-3'
(antisense) (Fleisher et al, 1999). Brieﬂy, 2 mg of genomic DNA
was denatured by treatment with NaOH and modiﬁed by sodium
bisulﬁte. DNA samples were then puriﬁed using a Wizard DNA
puriﬁcation resin (Promega, Madison, WI, USA), treated with
NaOH, precipitated with ethanol, and resuspended in 30 ml water.
Modiﬁed DNA was ampliﬁed in a total volume of 20 ml using
GeneAmp PCR Gold Buffer (PE Applied Biosystems, Foster City,
CA, USA) containing 1.0 mM MgCl2,2 0 mM of each primer,
0.2 mM dNTPs, and 1 unit of Taq polymerase (AmpliTaq Gold
DNA Polymerase, PE Applied Biosystems). After activation of the
Taq polymerase at 958C for 10 min, PCR was performed in a ther-
mal cycler (GeneAmp 9700, PE Applied Biosystems) for 35 cycles,
each cycle consisting of denaturation at 958C for 15 s, annealing at
558C for 15 s, and extension at 728C for 30 s, followed by a ﬁnal
7 min extension at 728C. The PCR products were then loaded onto
a non-denaturing 6% polyacrylamide gel, stained with ethidium
bromide, and visualized under UV illumination.
Immunohistochemistry
Immunohistochemistry was performed on formalin-ﬁxed, parafﬁn
embedded sections using a standard labelled streptavidin-biotin
system (Nichirei, Tokyo, Japan). Mouse monoclonal antibody to
the hMLH1 gene product, G168-728 (PharMingen, San Diego,
CA, USA), was used at 1:50 dilution after antigen retrieval by
microwave.
Statistical analysis
Statistical comparisons were performed using Fisher’s exact test. P
values 50.05 were considered signiﬁcant.
RESULTS
Hypermethylation of the hMLH1 gene promoter was detected in all
solitary (12 out of 12) and multiple (8 out of 8) gastric cancers
with MSI-H (Figure 1 and Table 1). Methylated alleles were found
in none (0 out of 5) of solitary and 20% (1 out of 5) of multiple
MSI-L and MSS tumours (Table 1). The MSI-L tumour did not
have methylated hMLH1 gene promoter alleles. The methylation
status of the hMLH1 promoter was signiﬁcantly correlated with
MSI status (P50.0000005). Methylated hMLH1 alleles were also
present in 50% (6 out of 12) and 63% (5 out of 8) of samples of
non-cancerous gastric mucosa adjacent to, and in 33% (4 out of
12) and 40% (2 out of 5) samples of non-cancerous gastric mucosa
distant from solitary and multiple gastric cancers with MSI-H
(Table 1). In contrast, methylated alleles were infrequently present
in none (0 out of 5) of non-cancerous mucosa adjacent to, and in
20% (1 out of 5) of non-cancerous mucosa distant from solitary
gastric cancers with MSS (Table 1). Most of the methylated
tumours (12 out of 12 solitary tumours and 7 out of 9 (78%) of
multiple tumours) showed an apparent loss of hMLH1 protein
expression (Figure 2). All nine unmethylated tumours (ﬁve solitary
and four multiple tumours) and their surrounding non-cancerous
mucosa had a normal expression level of hMLH1 protein. The
methylation status of the hMLH1 promoter was signiﬁcantly corre-
lated with protein expression in solitary and multiple tumours
(P50.000003, Table 2).
DISCUSSION
MSI is found in 15–33% of sporadic gastric cancers, a higher inci-
dence than that seen in other types of sporadic human cancers
(Chong et al, 1994; Mironov et al, 1994; Strickler et al, 1994;
Tamura et al, 1996; Ohmura et al, 2000). Furthermore, multiple
gastric cancers have a higher incidence of MSI than solitary gastric
cancers, although few studies have focused on the relationship
between multiple gastric cancers and MSI (Nakashima et al,
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Figure 1 Representative results from methylation-speciﬁc PCR (MSP) of
the hMLH1 gene promoter in multiple (A) and solitary (B) gastric cancers.
The presence of PCR product in lanes marked M indicates hypermethy-
lated hMLH1 product, lanes marked U indicate unmethylated hMLH1.T ,
Tumour DNA; A, normal mucosa adjacent to tumour; N, normal mucosa
from the surgical margin; PC, positive control; NC, negative control; SM,
size marker.
Table 1 Frequencies of hMLH1 promoter hypermethylation in solitary
and multiple gastric cancers and noncancerous mucosa
MSI status Tumour Normal 1 Normal 2
Solitary
MSI–H 100% (12/12) 50% (6/12) 33% (4/12)
MSS 0% (0/5) 0% (0/5) 20% (1/5)
Multiple
MSI–H 100% (8/8) 63% (5/8)
40% (2/5)
MSI-L and MSS 20% (1/5) 20% (1/5)
Normal 1, non-cancerous mucosae adjacent to each tumour; Normal 2, non-cancer-
ous mucosae at surgical margin from each patient (17 patients with solitary tumour
and ﬁve patients with multiple tumour).
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observed in 58.3% (7 out of 12) – 80% (4 out of 5) of multiple
gastric cancer patients, and in 30.3% (10 out of 33) – 71.4%
(10 out of 14) of individual tumours (Nakashima et al, 1995;
Yamashita et al, 2000; Ogata et al, 2001). These data suggest that
MSI may play a more important role in the development of multi-
ple rather than solitary gastric cancers. Recent studies suggest that
silencing of the hMLH1 gene by promoter hypermethylation is a
major causative event in the development of human gastric cancers
with MSI (Fleisher et al, 1999, 2001; Kang et al, 1999; Leung et al,
1999; Suzuki et al, 1999). hMLH1 promoter hypermethylation was
observed in 62.5–100% of sporadic gastric cancers with MSI-H
(Fleisher et al, 1999, 2001; Kang et al, 1999; Leung et al, 1999;
Suzuki et al, 1999). The majority of these tumours also exhibited
loss of hMLH1 protein expression. In our present study, hMLH1
promoter hypermethylation occurred in both solitary (12 out of
12) and multiple gastric cancers (8 out of 8) exhibiting MSI-H,
and all but two tumour samples also had an apparent loss of
hMLH1 protein expression. Toyota et al (1999b) examined the
methylation status of multiple CpG islands in the DNA from
normal gastric mucosa adjacent to gastric tumours with a CpG
island methylator phenotype, and found that hypermethylation
was rarely detected. Similar ﬁndings of hMLH1 gene promoter
were reported by other investigators (Suzuki et al, 1999; Leung et
al, 2001). In our present study, however, methylation of the
hMLH1 promoter was detected in non-cancerous mucosa adjacent
to both solitary (6 out of 12, 50%) and multiple (5 out of 8, 63%)
gastric tumours with MSI-H. Similarly to our present results, Guo
et al (2001) has recently reported a high frequency (40%; 4 out of
10) of hMLH1 methylation in non-cancerous mucosa adjacent to
gastric cancer showing MSI-H. The exact cause of these discrepan-
cies among reports remains uncertain. However, because
hypermethylation originates within the ﬂanking regions of the
CpG islands (Graff et al, 1997) and the more 3' region of hMLH1
promoter than we studied displayed a higher degree of correlation
with MSI status (Deng et al, 1999; Nakagawa et al, 2001), it is
possible that hMLH1 promoter was not yet fully methylated (or
silenced) in non-cancerous mucosa in which reduction of hMLH1
expression was inconspicuous. Alternatively, MSI-H gastric cancers
may develop through clonal expansion of fully methylated cells
showing loss of hMLH1. Such a ﬁnding has been previously
reported in colorectal tissue (Kuismanen et al, 1999).
Multiple gastric cancers are frequently found in the elderly, and
the incidence of gastric cancers with MSI-H also correlates with age
(Esaki et al, 1987; Nakashima et al, 1995; dos Santos et al, 1996;
Halling et al, 1999). Furthermore, hypermethylation of the promo-
ters of several tumour-related genes is also increased with age
(Ahuja et al, 1997, 1998; Kane et al, 1997; Veigl et al, 1998). Thus,
age-related methylation has the potential to behave as a mutator
process resulting in the simultaneous silencing of multiple tumour
related genes in aging tissues (Lipkin, 1988; Issa, 2000). While the
mechanism of age-related methylation is not known, it is clear that
age-related methylation only affects a subset of genes, suggesting a
gene-speciﬁc susceptibility to this process (Issa, 2000). Several
factors have been suggested to modulate this process, such as
exogenous carcinogens, endogenously generated reactive oxygen
species, and genetic differences in individuals’ susceptibility to
age-related methylation (Issa, 2000). Although we found frequent
hypermethylation of the hMLH1 gene promoter in non-cancerous
mucosa adjacent to, or distant from solitary and multiple gastric
cancers with MSI-H, methylated alleles were rarely detected in
similar tissues from patients with solitary gastric cancer of the
MSS phenotype. We conclude that hypermethylation of the
hMLH1 gene promoter occurs in the non-cancerous mucosa which
varies signiﬁcantly among individuals and may lead to the develop-
ment of MSI-H gastric cancer. Such methylation in non-cancerous
mucosa may also increase the risk of subsequent neoplasia.
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Figure 2 Immunohistochemical staining for hMLH1 protein expression
in gastric cancers with unmethylated (A) or hypermethylated (B) gene
promoters. (A) Nuclear staining of hMLH1 in a MSS tumour without
promoter hypermethylation (intramucosal well differentiated tubular
adenocarcinoma). (B) Loss of hMLH1 expression in a MSI-H tumour with
promoter hypermethylation (left, intramucosal well differentiated tubular
adenocarcinoma; right, intestinal metaplastic mucosa exhibiting hMLH1 ex-
pression).
Table 2 Promoter hypermethylation and protein expression of the
hMLH1 gene
hMLH1 expression
Methylation status Reduced Normal
Methylated
Solitary 12 0
Multiple 7 2
Total 19 2
Unmethylated
Solitary 0 5 P50.000003
Multiple 0 4
Total 0 9 ]
hMLH1 hypermethylation in multiple gastric cancer
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